Sales 2020
32 724 M 5 052 M 5 052 M
Net income 2020
4 641 M 716 M 716 M
Net cash position 2020
19 185 M 2 962 M 2 962 M
P/E ratio 2020
35,8x
Yield 2020
1,76%
Sales 2021
36 016 M 5 560 M 5 560 M
Net income 2021
5 143 M 794 M 794 M
Net cash position 2021
20 882 M 3 224 M 3 224 M
P/E ratio 2021
32,2x
Yield 2021
1,96%
Capitalization
168 B 25 878 M 25 880 M
EV / Sales 2020
4,54x
EV / Sales 2021
4,07x
Nbr of Employees
8 124
Free-Float
33,3%
Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory.
China accounts for 97.8% of net sales.
Notations Surperformance© of Yunnan Baiyao Group Co.,Ltd
Trading Rating : Investor Rating :
All news about YUNNAN BAIYAO GROUP CO.,LTD
News in other languages on YUNNAN BAIYAO GROUP CO.,LTD
Chart YUNNAN BAIYAO GROUP CO.,LTD
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends YUNNAN BAIYAO GROUP CO.,LTD
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
13
Average target price
128,33 CNY
Last Close Price
131,51 CNY
Spread / Highest target
20,1%
Spread / Average Target
-2,42%
Spread / Lowest Target
-23,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
